Molecular Docking of HIV-1 env gp120 Using Diterpene Lactones from Andrographis paniculat

dc.contributor.authorKabir OO*, Abdulfatai TA and Akeem AJ
dc.date.accessioned2025-03-17T12:18:39Z
dc.date.available2025-03-17T12:18:39Z
dc.date.issued2015-08-11
dc.description.abstractThe search for effective drugs to treat HIV/AIDS has been the major task of most researchers since several years of its discovery. Most synthetic drugs such as Efavirenz, Tenofovir, Emtricibatine among others are employed in the antiretroviral treatment which have dangerous effects on patients. Thus, herbal medicine can be used as an alternative source of treatment for HIV positive patients as they exhibit little or no side effects when compared to synthetic drugs. This research work sought to examine whether plant diterpene lactones isolated from Andrographis paniculata exhibit anti-HIV activity using molecular docking studies. The HIV-1 env gp120 was docked by two diterpene lactones namely; andrographolide and neoandrographolide using docking tool (igemdock v2.1) after retrieving protein structure from Protein Data Bank (PDB). The result indicates that neoandrographolide is a more promising drug against HIV-1 than andrographolide due to its low interaction energy for the formation of ligand-receptor complex
dc.identifier.citationKabir OO, Abdulfatai TA, Akeem AJ (2015) Molecular Docking of HIV 1 env gp120 Using Diterpene Lactones from Andrographis paniculata. Organic Chem Curr Res 4:150. doi:10.4172/2161-0401.1000150
dc.identifier.issn2161-0401 OCCR
dc.identifier.urihttps://kwasuspace.kwasu.edu.ng/handle/123456789/4828
dc.language.isoen
dc.publisherOrganic Chem Curr Res
dc.titleMolecular Docking of HIV-1 env gp120 Using Diterpene Lactones from Andrographis paniculat
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Otun et al., 2015b.pdf
Size:
317.21 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: